MIRM News
Mirum Pharmaceuticals, Inc.
$80.39
-$2.71(-3.26%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
788.21K
52W Range
$63.23 - $130.00
Target Price
--
MIRM news: the latest Mirum Pharmaceuticals, Inc. headlines, press releases and market updates, newest first.
Latest MIRM News
- TD Cowen Sticks to Its Buy Rating for Mirum Pharmaceuticals (MIRM)TipRanks Auto-Generated Intelligence Newsdesk · Oct 21, 2026
- Mirum’s AZURE-2 Trial Pits Brelovitug Against Bulevirtide in High-Stakes Hepatitis D StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 8, 2026
- Mirum Advances MRM-3379 With Completed Phase 1 ADME StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 7, 2026
- Wall Street Analysts Are Bullish on Top Healthcare PicksTipRanks Newsroom · Sep 29, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MIRM | $80.39 | -3.3% | 788.21K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mirum Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW